144 related articles for article (PubMed ID: 10672306)
21. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas.
Parsa CF; Givrad S
Br J Ophthalmol; 2008 Jan; 92(1):40-6. PubMed ID: 17962395
[TBL] [Abstract][Full Text] [Related]
22. Gliomas.
Collins VP
Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
[TBL] [Abstract][Full Text] [Related]
23. Expression of tissue factor in glioma.
Hamada K; Kuratsu J; Saitoh Y; Takeshima H; Nishi T; Ushio Y
Noshuyo Byori; 1996 Nov; 13(2):115-8. PubMed ID: 8958516
[TBL] [Abstract][Full Text] [Related]
24. Histopathology, classification, and grading of gliomas.
Kleihues P; Soylemezoglu F; Schäuble B; Scheithauer BW; Burger PC
Glia; 1995 Nov; 15(3):211-21. PubMed ID: 8586458
[TBL] [Abstract][Full Text] [Related]
25. An autoradiographic study of human gliomas: growth kinetics of anaplastic astrocytoma and glioblastoma multiforme.
Hoshino T; Townsend JJ; Muraoka I; Wilson CB
Brain; 1980 Dec; 103(4):967-84. PubMed ID: 6254610
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical detection of p53 in human gliomas.
Bruner JM; Saya H; Moser RP
Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878
[TBL] [Abstract][Full Text] [Related]
27. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
28. Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.
Sallinen PK; Sallinen SL; Helén PT; Rantala IS; Rautiainen E; Helin HJ; Kalimo H; Haapasalo HK
Neuropathol Appl Neurobiol; 2000 Aug; 26(4):319-31. PubMed ID: 10931365
[TBL] [Abstract][Full Text] [Related]
29. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
30. Glycosphingolipids of human gliomas.
Jennemann R; Rodden A; Bauer BL; Mennel HD; Wiegandt H
Cancer Res; 1990 Dec; 50(23):7444-9. PubMed ID: 2253195
[TBL] [Abstract][Full Text] [Related]
31. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
32. Potential ganglioside antigens associated with human gliomas.
Fredman P; von Holst H; Collins VP; Ammar A; Dellheden B; Wahren B; Granholm L; Svennerholm L
Neurol Res; 1986 Jun; 8(2):123-6. PubMed ID: 2875407
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of molecular alterations in microdissected archival gliomas.
Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
[TBL] [Abstract][Full Text] [Related]
34. Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.
Wikstrand CJ; He XM; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
J Neuropathol Exp Neurol; 1991 Nov; 50(6):756-69. PubMed ID: 1748882
[TBL] [Abstract][Full Text] [Related]
35. Ganglioside Composition Distinguishes Anaplastic Ganglioglioma Tumor Tissue from Peritumoral Brain Tissue: Complementary Mass Spectrometry and Thin-Layer Chromatography Evidence.
Fabris D; Karmelić I; Muharemović H; Sajko T; Jurilj M; Potočki S; Novak R; Vukelić Ž
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445547
[TBL] [Abstract][Full Text] [Related]
36. Proliferative index in astrocytic tumours.
Rathi KR; Radotra BD; Khosla VK
Indian J Pathol Microbiol; 2007 Oct; 50(4):754-8. PubMed ID: 18306542
[TBL] [Abstract][Full Text] [Related]
37. [Lipid composition of human malignant brain tumors].
Nakamura O; Ishihara E; Iwamori M; Nagai T; Matsutani M; Nomura K; Takakura K
No To Shinkei; 1987 Mar; 39(3):221-6. PubMed ID: 3034315
[TBL] [Abstract][Full Text] [Related]
38. Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors.
Fredman P
Prog Brain Res; 1994; 101():225-40. PubMed ID: 8029453
[TBL] [Abstract][Full Text] [Related]
39. Neuropathology of malignant gliomas.
Bruner JM
Semin Oncol; 1994 Apr; 21(2):126-38. PubMed ID: 8153659
[TBL] [Abstract][Full Text] [Related]
40. Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas.
Longee DC; Wikstrand CJ; Månsson JE; He X; Fuller GN; Bigner SH; Fredman P; Svennerholm L; Bigner DD
Acta Neuropathol; 1991; 82(1):45-54. PubMed ID: 1659106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
